Heat Biologics (HTBX) Posts Q3 Loss of 46c/Share

Heat Biologics (NASDAQ: HTBX) reported Q3 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Heat Biologics (HTBX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c